User


Gary Cox
Company
Wrays
Position
Principle
Country
Australia
Email Address
gary.cox@wrays.com.au
Phone
+61 413 316 180
Contacts (0) View all
Gary Cox
Principle at Wrays
Professional Details

Gary's practice extends across the following areas in biotechnology and pharmaceuticals:

  • advise towards strategic IP development in start-up companies and SME's;
  • drafting patent applications;
  • prosecution of patent applications;
  • opinion work, including freedom to operate opinions, opinions for regulatory approval of pharmaceuticals as well as general due diligence opinion; and
  • contentious matters including oppositions and court actions (infringement and revocation actions) in Australia and New Zealand.

Some leading cases that Gary has acted in are:

(1) Genetics Institute Inc v Kirin-Amgen Inc (1996) 34 IPR 513 (Acted for Kirin Amgen);

(2) Pfizer Overseas Pharmaceuticals v Eli Lilly and Co (2005) 225 ALR 416 (Acted for Eli Lilly and Co);

(3) Genentech, Inc v Ludwig Institute for Cancer Research and Human Genome Sciences, Inc [2006] APO 20 (5 June 2006) (Acted for Human Genome Sciences Inc); and

(4) Danisco A/S v Novozymes A/S (No 2) [2011] FCA 282 (29 March 2011) (Acted for Danisco A/S).

close

Subscribe to our newsletter

Sign up here and get the latest news and updates delivered directly to your inbox

You can unsubscribe at any time